ZNF81 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.067200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.807600E-01
Normal-vs-Stage2
1.831640E-01
Normal-vs-Stage3
2.193600E-01
Normal-vs-Stage4
9.020600E-01
Stage1-vs-Stage2
6.568100E-02
Stage1-vs-Stage3
6.377700E-03
Stage1-vs-Stage4
8.199000E-01
Stage2-vs-Stage3
6.535500E-02
Stage2-vs-Stage4
6.732100E-02
Stage3-vs-Stage4
1.028180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.038200E-01
Normal-vs-AfricanAmerican
7.221200E-01
Normal-vs-Asian
7.934500E-02
Caucasian-vs-AfricanAmerican
3.267400E-01
Caucasian-vs-Asian
1.249950E-01
AfricanAmerican-vs-Asian
8.038200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.811230E-01
Normal-vs-Female
2.640200E-01
Male-vs-Female
7.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.284000E-01
Normal-vs-Age(41-60Yrs)
4.340800E-01
Normal-vs-Age(61-80Yrs)
1.514020E-01
Normal-vs-Age(81-100Yrs)
9.318100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.629000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.913800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.004830E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.098400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.324200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.631600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.058000E-01
Normal-vs-Daily Drinker
6.663600E-02
Normal-vs-Weekly Drinker
2.603800E-01
Normal-vs-Occasional Drinker
3.309400E-01
Normal-vs-Social Drinker
6.455400E-01
Non Drinker-vs-Daily Drinker
5.981800E-01
Non Drinker-vs-Weekly Drinker
5.651200E-01
Non Drinker-vs-Occasional Drinker
1.772760E-01
Non Drinker-vs-Social Drinker
1.204000E-01
Daily Drinker-vs-Weekly Drinker
3.744000E-01
Daily Drinker-vs-Occasional Drinker
1.089160E-01
Daily Drinker-vs-Social Drinker
5.035900E-02
Weekly Drinker-vs-Occasional Drinker
6.010200E-01
Weekly Drinker-vs-Social Drinker
3.301200E-01
Occasional Drinker-vs-Social Drinker
5.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.741800E-02
Normal-vs-Grade 2
3.671700E-02
Normal-vs-Grade 3
3.539800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.456800E-01
Grade 1-vs-Grade 3
6.983000E-01
Grade 1-vs-Grade 4
9.741800E-02
Grade 2-vs-Grade 3
7.581800E-01
Grade 2-vs-Grade 4
3.671700E-02
Grade 3-vs-Grade 4
3.539800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.311200E-01
Normal-vs-NonDiabetic
1.321150E-01
Diabetic-vs-NonDiabetic
7.222800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.530800E-01
Normal-vs-NoPancreatitis
1.371020E-01
Pancreatitis-vs-NoPancreatitis
8.916000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.502000E-01
Normal-vs-N1
2.075800E-01
N0-vs-N1
9.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.512200E-01
Normal-vs-TP53-NonMutant
4.577800E-01
TP53-Mutant-vs-TP53-NonMutant
6.929800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
